MUSC leader to highlight PTSD research on Capitol Hill

Veteran’s Day, observed on Saturday, is a time dedicated to honoring and expressing gratitude to those who have served our country, many of whom grapple with post-traumatic stress disorder (PTSD). Advocating for the advancement and funding of PTSD research and therapies, a leader from the Medical University of South Carolina (MUSC) is poised to address Congress during the Congressional Neuroscience Caucus Briefing in the coming days.

PTSD is prevalent among veterans and can significantly disrupt their everyday lives. Dr. Lori McMahon, MUSC’s Vice President for Research, along with other experts, will enlighten Congress on the crucial role of brain research in understanding and treating PTSD. The briefing aims to highlight the necessity for funding to support further discoveries in this field.

McMahon outlined specific topics that the panelists will cover, including strategies to assist the brain in self-repair and discussions on interventions like cognitive therapy and its combination with pharmaceuticals to help patients overcome PTSD challenges. MUSC stands as a leader in both fundamental discovery and patient care related to PTSD.

“Our team travels across the country in response to traumatic events, providing assistance to victims in their recovery efforts. Through this work, we contribute to preventing and minimizing the risk of PTSD,” McMahon emphasized.

The Congressional Briefing is scheduled to take place from November 11 to November 15 on Capitol Hill, where experts like McMahon aim to recognize and share effective approaches for the treatment of this neuropsychiatric disorder moving forward.